Taiwan’s FDA Orders Recall of Hypothyroidism Drug Over Low Active Ingredient Levels
Taipei: Taiwan’s Food and Drug Administration (FDA) has initiated a recall of two batches of a hypothyroidism medication after stability tests revealed that the levels of its active ingredient, levothyroxine